This indicates 11q22 deletions as part of the explanation to the recurrent decreased YAP1 protein levels in breast cancer, but also supports the possibility of additional unknown mechanisms contributing to YAP1 protein loss in breast cancer [25,31-33]. Here, YAP1 is linked to breast carcinoma.